Kevin D. Burris

2.5k total citations · 1 hit paper
38 papers, 2.0k citations indexed

About

Kevin D. Burris is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Kevin D. Burris has authored 38 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Kevin D. Burris's work include Receptor Mechanisms and Signaling (14 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Neuroscience and Neuropharmacology Research (8 papers). Kevin D. Burris is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Neuroscience and Neuropharmacology Research (8 papers). Kevin D. Burris collaborates with scholars based in United States, Japan and Germany. Kevin D. Burris's co-authors include Tetsuro Kikuchi, Perry B. Molinoff, Katsura Tottori, Frank D. Yocca, Thaddeus F. Molski, Cen Xu, Elaine Ryan, Elaine Sanders‐Bush, Takashi Miwa and Arlene Stark and has published in prestigious journals such as Journal of Biological Chemistry, Brain Research and The FASEB Journal.

In The Last Decade

Kevin D. Burris

38 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

2002 736 citations Kevin D. Burris, Thaddeus F. Molski et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin D. Burris United States	19	900	719	694	287	225	38	2.0k
Katsura Tottori Japan	16	828 0.9×	1.1k 1.5×	637 0.9×	304 1.1×	160 0.7×	23	2.1k
Frank D. Yocca United States	26	1.2k 1.4×	699 1.0×	856 1.2×	298 1.0×	154 0.7×	51	2.3k
Stevin H. Zorn United States	20	954 1.1×	662 0.9×	795 1.1×	225 0.8×	111 0.5×	37	2.2k
Anton A. H. P. Megens Belgium	22	878 1.0×	613 0.9×	653 0.9×	223 0.8×	81 0.4×	45	1.9k
Per Plenge Denmark	29	1.2k 1.3×	768 1.1×	824 1.2×	458 1.6×	124 0.6×	95	2.4k
Paul Van Gompel Belgium	15	1.3k 1.4×	616 0.9×	895 1.3×	214 0.7×	112 0.5×	26	2.1k
Kimberly E. Vanover United States	26	731 0.8×	705 1.0×	619 0.9×	364 1.3×	91 0.4×	67	2.0k
Cen Xu United States	22	775 0.9×	797 1.1×	615 0.9×	157 0.5×	86 0.4×	52	1.9k
Philip Seeman Canada	14	779 0.9×	865 1.2×	556 0.8×	161 0.6×	125 0.6×	16	1.7k
R J Baldessarini United States	28	946 1.1×	566 0.8×	746 1.1×	229 0.8×	99 0.4×	62	2.1k

Countries citing papers authored by Kevin D. Burris

Since Specialization

Citations

This map shows the geographic impact of Kevin D. Burris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin D. Burris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin D. Burris more than expected).

Fields of papers citing papers by Kevin D. Burris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin D. Burris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin D. Burris. The network helps show where Kevin D. Burris may publish in the future.

Co-authorship network of co-authors of Kevin D. Burris

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin D. Burris. A scholar is included among the top collaborators of Kevin D. Burris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin D. Burris. Kevin D. Burris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burris, Kevin D., et al.. (2019). Development of an Electrophysiological Assay for Kv7 Modulators on IonWorks Barracuda. Assay and Drug Development Technologies. 17(7). 310–321. 2 indexed citations

Cerne, Rok, Mark Wakulchik, Michael J. Krambis, Kevin D. Burris, & Birgit T. Priest. (2016). IonWorks Barracuda Assay for Assessment of State-Dependent Sodium Channel Modulators. Assay and Drug Development Technologies. 14(2). 84–92. 3 indexed citations

Cerne, Rok, Mark Wakulchik, Baolin Li, Kevin D. Burris, & Birgit T. Priest. (2015). Optimization of a High-Throughput Assay for Calcium Channel Modulators on IonWorks Barracuda. Assay and Drug Development Technologies. 14(2). 75–83. 2 indexed citations

Brust, Tarsis F., Michael P. Hayes, David L. Roman, Kevin D. Burris, & Val J. Watts. (2014). Bias Analyses of Preclinical and Clinical D2 Dopamine Ligands: Studies with Immediate and Complex Signaling Pathways. Journal of Pharmacology and Experimental Therapeutics. 352(3). 480–493. 32 indexed citations

Conley, Jason M., Tarsis F. Brust, Ruqiang Xu, Kevin D. Burris, & Val J. Watts. (2014). Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications. Journal of Visualized Experiments. e51218–e51218. 6 indexed citations

Vrudhula, Vivekananda M., Sokhom S. Pin, Kevin D. Burris, et al.. (2010). Design, synthesis and evaluation of constrained tetrahydroimidazopyrimidine derivatives as antagonists of corticotropin-releasing factor type 1 receptor (CRF1R). Bioorganic & Medicinal Chemistry Letters. 20(6). 1905–1909. 4 indexed citations

Sit, S.Y., Charles M. Conway, Kai Xie, et al.. (2009). Oxime Carbamate—Discovery of a series of novel FAAH inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(3). 1272–1277. 23 indexed citations

Stark, Arlene, Shaun Jordan, Kelly A. Allers, et al.. (2006). Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies. Psychopharmacology. 190(3). 373–382. 119 indexed citations

Han, Xiaojun, Sokhom S. Pin, Kevin D. Burris, et al.. (2005). Synthesis and structure–activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(18). 4029–4032. 34 indexed citations

10.

Nakai, Satoru, Tsuyoshi Hirose, Yasufumi Uwahodo, et al.. (2003). Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. European Journal of Pharmacology. 472(1-2). 89–97. 39 indexed citations

11.

Sit, Sing‐Yuen, Kai Xie, Matthew T. Taber, et al.. (2002). (+)-Dinapsoline: An Efficient Synthesis and Pharmacological Profile of a Novel Dopamine Agonist. Journal of Medicinal Chemistry. 45(17). 3660–3668. 13 indexed citations

12.

Burris, Kevin D., et al.. (2002). Aripiprazole: A dopamine-serotonin system stabilizer. European Neuropsychopharmacology. 12. 290–291. 34 indexed citations

13.

Burris, Kevin D., Thaddeus F. Molski, Cen Xu, et al.. (2002). Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors. Journal of Pharmacology and Experimental Therapeutics. 302(1). 381–389. 736 indexed citations breakdown →

14.

Burris, Kevin D., et al.. (1997). Regulation of D2 and D3 Receptors in Transfected Cells by Agonists and Antagonists. Advances in pharmacology. 42. 443–446. 3 indexed citations

15.

Burris, Kevin D., Mary A. Pacheco, Theresa M. Filtz, et al.. (1995). Lack of Discrimination by Agonists for D2 and D3 Dopamine Receptors. Neuropsychopharmacology. 12(4). 335–345. 27 indexed citations

16.

Butkerait, Paul, Hazem Hallak, Timothy E. Graham, et al.. (1995). Expression of the Human 5-Hydroxytryptamine1A Receptor in Sf9 Cells. Journal of Biological Chemistry. 270(31). 18691–18699. 143 indexed citations

17.

Burris, Kevin D. & Elaine Sanders‐Bush. (1992). Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.. Molecular Pharmacology. 42(5). 826–830. 18 indexed citations

18.

Sanders‐Bush, Elaine, Manami Tsutsumi, & Kevin D. Burris. (1990). Serotonin Receptors and Phosphatidylinositol Turnover^a. Annals of the New York Academy of Sciences. 600(1). 224–235. 34 indexed citations

19.

Nichols, David E., Robert Oberlender, Kevin D. Burris, Andrew J. Hoffman, & Michael P. Johnson. (1989). Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analogues. Pharmacology Biochemistry and Behavior. 34(3). 571–576. 10 indexed citations

20.

Johnson, Jerry D., William G. Conroy, Kevin D. Burris, & Gary E. Isom. (1987). Peroxidation of brain lipids following cyanide intoxication in mice. Toxicology. 46(1). 21–28. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact